Harmony Total Current Liabilities from 2010 to 2024
| HRMY Stock | USD 29.03 0.16 0.55% |
Total Current Liabilities | First Reported 2010-12-31 | Previous Quarter 163.8 M | Current Value 84 M | Quarterly Volatility 52.1 M |
Check Harmony Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harmony main balance sheet or income statement drivers, such as Tax Provision of 28.4 M, Depreciation And Amortization of 25.6 M or Interest Expense of 17.9 M, as well as many exotic indicators such as Price To Sales Ratio of 3.14, Dividend Yield of 0.0029 or PTB Ratio of 4.32. Harmony financial statements analysis is a perfect complement when working with Harmony Biosciences Valuation or Volatility modules.
Harmony | Total Current Liabilities |
Latest Harmony Biosciences' Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of Harmony Biosciences Holdings over the last few years. Total Current Liabilities is an item on Harmony Biosciences balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Harmony Biosciences Holdings are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Harmony Biosciences' Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harmony Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
Harmony Total Current Liabilities Regression Statistics
| Arithmetic Mean | 39,995,691 | |
| Geometric Mean | 18,270,758 | |
| Coefficient Of Variation | 130.20 | |
| Mean Deviation | 41,998,121 | |
| Median | 7,231,000 | |
| Standard Deviation | 52,074,387 | |
| Sample Variance | 2711.7T | |
| Range | 156.6M | |
| R-Value | 0.74 | |
| Mean Square Error | 1300.4T | |
| R-Squared | 0.55 | |
| Significance | 0 | |
| Slope | 8,672,384 | |
| Total Sum of Squares | 37964.4T |
Harmony Total Current Liabilities History
About Harmony Biosciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Harmony Biosciences income statement, its balance sheet, and the statement of cash flows. Harmony Biosciences investors use historical funamental indicators, such as Harmony Biosciences's Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although Harmony Biosciences investors may use each financial statement separately, they are all related. The changes in Harmony Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Harmony Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Harmony Biosciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Harmony Biosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 163.8 M | 84 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Harmony Biosciences Correlation against competitors. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Harmony Stock analysis
When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
Is Harmony Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harmony Biosciences. If investors know Harmony will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harmony Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Earnings Share 2.13 | Revenue Per Share 9.787 | Quarterly Revenue Growth 0.313 | Return On Assets 0.1616 |
The market value of Harmony Biosciences is measured differently than its book value, which is the value of Harmony that is recorded on the company's balance sheet. Investors also form their own opinion of Harmony Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Harmony Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harmony Biosciences' market value can be influenced by many factors that don't directly affect Harmony Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harmony Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Harmony Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harmony Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.